Auna Reports Preliminary Key Performance Indicators for the First Quarter ended March 31, 2026

Key Terms

intravenous chemotherapy medical

Intravenous chemotherapy is cancer medication given directly into a vein so the drug quickly enters the bloodstream and circulates through the body. Think of it as delivering medicine via a main highway rather than a local road: it reaches tumors systemwide and is typically administered in a clinic or hospital. For investors, the route of administration matters because it affects treatment costs, provider settings, required equipment, patient convenience, reimbursement, and the competitive position of drug formulations and delivery technologies.

radiotherapy medical

Radiotherapy is a medical treatment that uses targeted high-energy radiation to shrink or destroy tumors and control disease, similar to using a focused beam to remove weeds without digging up the whole garden. It matters to investors because approvals, new technologies, clinical trial results, or changes in treatment guidelines can affect demand for equipment, drug combinations, and patient outcomes, which in turn influence revenue and growth prospects for healthcare companies.

icu medical

An ICU, or intensive care unit, is a hospital ward equipped and staffed to monitor and treat patients with life‑threatening illnesses or injuries that require constant attention and advanced medical support, like breathing machines or continuous medication. For investors, ICU capacity and related costs matter because high demand can signal increased use of hospital services, drive revenue for medical device and healthcare providers, strain a facility’s resources and margins, and influence regulatory and reimbursement pressures—similar to how a factory’s production line affects a manufacturer’s output and costs.

total capacity utilization technical

Total capacity utilization measures the share of a company’s or facility’s maximum possible output that is actually being produced, expressed as a percentage. Think of a factory running at 80% capacity like a car with 80% of its seats filled; higher utilization usually means the business is using its assets efficiently and can boost profits, while low utilization may signal excess capacity, weak demand, or the need for cost adjustments—factors investors watch to judge future earnings and investment needs.

outpatient care technical

Outpatient care is medical treatment and services provided without an overnight hospital stay, including clinic visits, same-day surgeries, diagnostic tests and rehabilitation. Investors care because outpatient services tend to cost less, can be delivered at many locations, and scale more predictably than inpatient treatment—like a chain of neighborhood stores versus a single full-service hotel—so changes in outpatient demand, pricing and reimbursement affect healthcare revenue mix, margins and capital spending.

risk-sharing agreements financial

An agreement where two or more parties—often a drugmaker and a payer or insurer—share the financial outcomes of a product or project so that costs, revenues, or risks are divided according to pre-set terms. Investors care because these deals can reduce a company’s exposure to uncertain sales or performance, smoothing revenue swings and protecting margins much like a co-op insurance policy that limits how much any single member loses if something goes wrong.

LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the First Quarter ended March 31, 2026. The Company intends to publish these key performance indicators on a quarterly basis going forward, as part of its commitment to providing investors with more information and a clearer understanding of Auna.

Preliminary Key Performance Indicators As of first quarter ended March 31, 2026
Healthcare Services Mexico
Key Operating Metrics			1Q'25		2Q'25		3Q'25		4Q'25		1Q'26
Emergency treatments (1)	# (000)		8,053		8,170		7,274		8,002		7,864
Surgeries (2)	# (000)		4,687		4,904		5,177		5,028		4,855
Total number of days hospitalized (3)	#		25,344		24,791		25,450		24,156		25,122
Total Capacity Utilization (4)	%		39.8%		38.5%		39.1%		37.1%		39.4%
Chemotherapies & Radiotherapies (sessions) (5)	#		2,333		2,690		3,678		3,983		4,162
Healthcare Services Peru
Key Operating Metrics			1Q'25		2Q'25		3Q'25		4Q'25		1Q'26
Emergency treatments (1)	# (000)		37,866		47,602		49,049		47,885		45,485
Surgeries (2)	# (000)		5,360		5,438		5,034		4,973		5,851
Total number of days hospitalized (3)	#		24,990		25,789		26,912		26,486		26,428
Total Capacity Utilization (4)	%		74.0%		73.6%		76.0%		74.8%		76.3%
Chemotherapies & Radiotherapies (sessions) (5)	#		12,831		12,787		11,027		12,296		12,718
OncoSalud Peru
Key Operating Metrics			1Q'25		2Q'25		3Q'25		4Q'25		1Q'26
Plan Memberships (6)	# (000)		1,364,710		1,388,579		1,395,509		1,424,695		1,439,781
Healthcare Services Colombia
Key Operating Metrics			1Q'25		2Q'25		3Q'25		4Q'25		1Q'26
Emergency treatments (1)	# (000)		36,386		36,052		37,323		35,289		38,077
Surgeries (2)	# (000)		10,653		10,484		11,209		10,443		10,897
Total number of days hospitalized (3)	#		78,254		78,583		80,176		79,349		80,716
Total Capacity Utilization (4)	%		76.9%		76.4%		77.1%		76.3%		79.3%
Protected lives (7)	#		-		-		-		3,036,335		3,057,763
Chemotherapies & Radiotherapies (sessions) (5)	#		36,884		33,912		36,668		35,941		36,619

1) Emergency care includes the number of visits to the emergency rooms and may include several visits per patient.

2) Number of surgeries includes inpatient surgeries, outpatient surgeries and cesarean sections.

3) Total number of days during which any of Auna's beds were occupied by a hospitalized patient during the period, including ICU.

4) Total capacity utilization is calculated as (i) (x) total number of days in which any of Auna's beds had a hospitalized patient during the period divided by (y) total number of beds, times (ii) total number of days during the period.

5) Intravenous chemotherapy and radiotherapy infusions in both inpatient and outpatient care; excludes oral treatments. In Peru, includes sessions across the Healthcare Services Network and OncoSalud Segments.

6) As of period end and as reported to the National Superintendence of Health Susalud in Peru.

7) Insured population assigned to Auna under risk-sharing agreements in Colombia. Tracking began in 4Q25.

About Auna

Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of March 31, 2026, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,333 beds and 1.4 million health plan members.

Preliminary Information

The information contained in this press release is preliminary in nature and is provided for informational purposes only. It is based on current estimates, assumptions, and expectations, which remain subject to ongoing review, verification, and possible revision. Final first quarter ended March 31, 2026 Key Performance Indicators may differ from those set forth herein. Readers are cautioned not to place undue reliance on these preliminary results.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about our intention to publish these key performance indicators on a quarterly basis going forward. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements are described in Auna’s filings with the United States Securities and Exchange Commission, including its annual report filed on Form 20-F on April 10, 2025.

The forward-looking statements are made only as of the date hereof, and Auna does not undertake any obligation to (and expressly disclaims any obligation to) update any forward-looking statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated events. In light of the risks and uncertainties described above, and the potential for variation of actual results from the assumptions on which certain of such forward-looking statements are based, investors should keep in mind that the results, events or developments disclosed in any forward-looking statement made in this document may not occur, and that actual results may vary materially from those described herein, including those described as anticipated, expected, targeted, projected or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260416171913/en/

contact@aunainvestors.com

Source: Auna S.A.